A kind of Lactobacillus plantarum KSFY01 and application thereof

Through Lactobacillus plantarum KSFY01, the accumulation of metabolites and the regulation of Nrf2 signaling pathway was improved, and the problem of decreased exercise capacity caused by aging was solved, which significantly improved the antioxidant ability and exercise endurance of mice, providing food-borne anti-epidemic resistance for the improvement of exercise function in the elderly. Oxidant reference.

CN115873761BActive Publication Date: 2024-11-15CHONGQING UNIV OF EDUCATION

Patent Information

Application Number
CN202211407098.3
Authority / Receiving Office
CN · China
Patent Type
Patents(China)
Current Assignee / Owner
Filing Date
2022-11-10
Publication Date
2024-11-15
Estimated Expiration
2042-11-10

AI Technical Summary

Technical Problem

Aging leads to a decrease in the body's metabolic rate, imbalance in the antioxidant system, accumulation of free radicals, affecting exercise ability and quality of life. The existing technology lacks effective antioxidants to improve the motor function of the elderly.

Method used

It provides a Lactobacillus plantarum KSFY01, which regulates Nrf2 signaling pathways by improving metabolites accumulation, glycogen storage, muscle and liver and kidney damage, and improves the body's antioxidant ability and exercise endurance.

Benefits of technology

It significantly prolongs the running time of mice, reduces the levels of CK, ALT and AST in the serum, relieves liver, kidney and muscle damage, improves antioxidant ability, and enhances exercise ability, providing a reference for the development of food-borne antioxidants.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN115873761B_ABST
    Figure CN115873761B_ABST
Patent Text Reader

Abstract

The present invention discloses a plant lactobacillus KSFY01 and its application, belonging to the field of microorganisms. The strain has been deposited in the General Microbiological Center of China Microorganism Culture Collection Administration Committee, with a deposit number of CGMCC NO.15654, a deposit address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, China, and a deposit date of April 28, 2018. The present invention explores the antioxidant effect of strain KSFY01 and the effect of improving the motor ability of mice by establishing a mouse aging model. The experimental results show that the strain can improve the fatigue resistance and motor ability of aging mice by improving metabolite accumulation, glycogen storage, muscle and liver and kidney damage, and oxidative stress. It provides a reference for the future development of food-borne antioxidants for anti-fatigue and improving the motor function of the elderly, which is of great significance to the development and utilization of probiotic resources.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The invention relates to the field of microorganisms, and in particular to a Lactobacillus plantarum KSFY01 and an application thereof. Background Art

[0002] Aging is a comprehensive physiological change process and a stage that biological individuals must go through. At present, the aging of society is intensifying. It is estimated that by 2050, the global population over 60 years old will reach 2.1 billion. Aging will reduce the body's metabolic rate, unbalance the antioxidant system, and the accumulation of free radicals in the body due to the inability to be removed in time. The content of lipid peroxides in plasma and tissues increases, and the body's anti-fatigue ability gradually decreases. Studies have found that telomere length is preserved in healthy elderly people who perform intense aerobic exercise, and is positively correlated with maximum aerobic exercise capacity, indicating that good exercise capacity may delay aging. At the same time, people who exercise regularly have a slower heart rate, lower blood pressure and cholesterol levels, which directly reflect the association between exercise capacity and aging. The decline in organ and muscle function and increased fatigue caused by aging lead to a decline in exercise capacity; maintaining reasonable exercise can improve human function, relieve the body's fatigue state, and maintain the body's vitality. Therefore, body aging and exercise capacity affect each other. Body health is both a reflection of good exercise capacity, and good exercise capacity can promote continuous exercise, thereby delaying aging.

[0003] Under normal physiological conditions, organisms undergo aerobic metabolism and continuously produce oxygen free radicals (ROS) to attack tissue cells. When the damage capacity of oxygen free radicals is greater than the body's repair capacity, it will cause the body to age. At the same time, the antioxidant enzyme activity and non-enzymatic antioxidant capacity of the body decrease significantly during the aging process, causing the continuous accumulation of free radicals in the body, affecting normal metabolism, increasing the body's fatigue, and decreasing exercise capacity, resulting in a decline in the quality of life of the elderly. Therefore, there is a close connection between oxidative stress, aging, and exercise capacity. Intervening in the body's antioxidant capacity and enhancing exercise function is an effective way to delay aging; at the same time, the slowing of body aging also enhances the vitality of the body's organs and muscle activity, thereby promoting the strengthening of exercise function. Supplementing the body with exogenous antioxidants to prevent the oxidation of cellular oxidizable substrates, inhibit lipid peroxidation reactions, and directly remove oxygen free radicals in the body, thereby reducing oxidative stress in the body, is one of the effective ways to delay physical fatigue.

[0004] The development and utilization of probiotic lactic acid bacteria (LAB) functions is a hot topic in the field of food bioengineering at home and abroad. A large number of research results on the probiotic functional characteristics of lactic acid bacteria show that many lactic acid bacteria have antioxidant functions, but there are differences in the antioxidant capacity of different strains. There are many studies on probiotics, but there are few research reports on their effects on athletic ability at home and abroad. Summary of the invention

[0005] The purpose of the present invention is to provide a Lactobacillus plantarum KSFY01 and an application thereof to solve the problems existing in the above-mentioned prior art. The strain can improve the anti-fatigue ability and motor ability of an aging body by improving metabolite accumulation, glycogen storage, muscle and liver and kidney damage, and oxidative stress, thereby providing a reference for the future development of food-borne antioxidants for anti-fatigue and improving the motor function of the elderly, and is of great significance to the development and utilization of probiotic resources.

[0006] To achieve the above object, the present invention provides the following solutions:

[0007] The present invention provides a plant lactobacillus KSFY01, which has been deposited in the General Microbiological Center of China Microorganism Culture Collection Committee, with a deposit number of CGMCC No.15654, a deposit address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, China, and a deposit date of April 28, 2018.

[0008] The present invention also provides an application of the Lactobacillus plantarum KSFY01 in preparing a product for improving body exercise capacity.

[0009] Furthermore, by improving the body's exercise endurance, improving metabolite accumulation and alleviating body damage, the effect of relieving fatigue and improving the body's exercise ability is achieved.

[0010] Furthermore, the improvement of metabolite accumulation is specifically to reduce the levels of CK, ALT and AST in the body's serum.

[0011] Furthermore, the alleviating body damage includes alleviating liver, kidney and muscle damage; and the body includes an aging body.

[0012] The present invention also provides an application of the Lactobacillus plantarum KSFY01 in preparing an antioxidant product.

[0013] Furthermore, the Lactobacillus plantarum KSFY01 improves the body's antioxidant capacity by regulating the molecular expression of the body's Nrf2 signaling pathway.

[0014] The present invention also provides an application of the Lactobacillus plantarum KSFY01 in preparing a product for improving the anti-fatigue ability of an organism.

[0015] The present invention also provides a product for improving the body's athletic ability, anti-fatigue ability and slowing down the aging of the body, and the product comprises an effective dose of Lactobacillus plantarum KSFY01.

[0016] Furthermore, the plant lactobacillus KSFY01 comprises a plant lactobacillus KSFY01 bacterial suspension, and the effective dose of the bacterial suspension in the body is 1.0×10 9-1.0×10 10 CFU / kg.

[0017] The present invention discloses the following technical effects:

[0018] The present invention establishes a mouse aging model to explore the antioxidant effect of L. plantarum KSFY01 and the effect of improving the motor function of mice. The experimental results show that L. plantarum KSFY01 can improve the fatigue resistance and motor ability of aging mice by improving metabolite accumulation, glycogen storage, muscle and liver and kidney damage, and oxidative stress. It provides a reference for the future development of food-borne antioxidants for anti-fatigue and improving the motor function of the elderly, which is of great significance to the development and utilization of probiotic resources. BRIEF DESCRIPTION OF THE DRAWINGS

[0019] In order to more clearly illustrate the embodiments of the present invention or the technical solutions in the prior art, the drawings required for use in the embodiments will be briefly introduced below. Obviously, the drawings described below are only some embodiments of the present invention. For ordinary technicians in this field, other drawings can be obtained based on these drawings without paying creative work.

[0020] Figure 1 This is the Gram staining microscopic examination of the strain;

[0021] Figure 2 It is a schematic diagram of the experimental design process of the present invention;

[0022] Figure 3 is the exercise exhaustion time of each group of mice;

[0023] Figure 4 H&E pathological observation pictures of liver tissues of mice in each group;

[0024] Figure 5 H&E pathological observation pictures of kidney tissues of mice in each group;

[0025] Figure 6 is the mRNA expression in the liver tissue of mice in each group; AF is SOD1, SOD2, CAT, IL-10, IL-1β and TNF-α;

[0026] Figure 7 is the mRNA expression in the liver tissue of mice in each group; AD is HO-1, Nrf2, γ-GCS and NQO-1;

[0027] Figure 8 is the mRNA expression in skeletal muscle tissue of mice in each group; AF is SOD1, SOD2, CAT, IL-10, IL-1β and TNF-α;

[0028] Fig. 9 is the mRNA expression in skeletal muscle tissue of mice in each group; AD is HO-1, Nrf2, γ-GCS and NQO-1. DETAILED DESCRIPTION

[0029] 1 Materials and Methods

[0030] 1.1 Isolation, identification and preservation of experimental strains

[0031] 1.1.1 Isolation and purification of strains

[0032] Take 1 mL of yogurt sample and dilute it 10 times to 10 with sterile saline. -6 , then take 10 -4 , 10 -5 , 10 -6 100 μL of 3 gradient bacterial solutions were spread on the plate and cultured at 37℃ for 24-48h. The colony morphology was observed and recorded. Colonies with different morphologies on the plate were picked for streaking separation. After culturing at 37℃ for 48h, single colonies with different morphologies on the plate were picked for streaking separation again. This was repeated 2 to 3 times until pure single colonies with consistent morphology were obtained.

[0033] 1.1.2 Preliminary identification of lactic acid bacteria

[0034] Pick the pure colonies on the plate and inoculate them into 5 mL of MRS liquid medium and culture them at 37°C for 24 h. Take 1 mL of the above bacterial culture medium into a sterile centrifuge tube, centrifuge at 4000 r / min for 10 min, discard the upper culture medium, resuspend the bacterial pellet in sterile physiological saline and perform Gram staining microscopy. Under a 100x oil microscope, Gram staining observed the cell morphology of the lactobacillus strain as follows: Figure 1 As shown in the figure, the cell morphology includes long rods and short rods, and there is no budding. Gram staining microscopy was positive and was preliminarily identified as lactic acid bacteria.

[0035] 1.1.3 Lactic acid bacteria DNA extraction

[0036] Inoculate the purified suspected target strain into MRS broth, culture at 37℃ for 18-24h, and then use a bacterial genomic DNA extraction kit to extract DNA. Number the extracted DNA and store it in a -20℃ freezer for later use.

[0037] 1.1.4 PCR amplification of genomic DNA and detection by agarose gel electrophoresis

[0038] The extracted DNA was subjected to PCR amplification, including 1 μL of upstream primer 27F (5'-AGAGTTTGATCCTGGCTCAG-3'), 1 μL of downstream primer 1495R (5'-CTACGGCTACCTTGTTACGA-3'), 12.5 μL of 2×Taq plus Buffer, and 1 μL of template DNA. The system was supplemented to 25 μL with sterile dd H2O. Sterile ultrapure water was used to replace template DNA as a negative control. The amplification conditions were: 94℃5min; 94℃30s, 55℃30s, 72℃1min, a total of 29 cycles, and finally 72℃ extension for 5min.

[0039] Then take 5 μL of the amplified product for agarose gel electrophoresis detection, the agarose concentration is 1.5%, the electrophoresis conditions are 110V, 45min. The successfully detected PCR product was sent to Beijing Qingke Biotechnology Co., Ltd. for sequencing, and the sequencing results are as follows:

[0040] TGGGGGCTGCTATGATGCAAGTCGAACGAACTCTGGTATTGATTGGTGCTTGCATCAT GATTTACATTTGAGTGAGTGGCGAACTGGTGAGTAACACGTGGGAAACCTGCCCAGAAGCGGGGGATAACACCTGGAAACAGATGCTAATACCGCATAACAACTTGGACCGCATGGTCC GAGTTTGAAAGATGGCTTCGGCTATCACTTTTGGATGGTCCCGCGGCGTATTAGCTAGATGGTGGGGTAACGGCTCACCATGGCAATGATACGTAGCCGACCTGAGAGGGTAATCGGCCA CATTGGGACTGAGACACGGCCCAAACTCCTACGGGAGGCAGCAGTAGGGAATCTTCCACAATGGACGAAAGTCTGATGGAGCAACGCCGCGTGAGTGAAGAAGGGTTTCGGCTCGTAA AACTCTGTTGTTAAAGAAGAACATATCTGAGAGTAACTGTTCAGGTATTGACGGTATTTAACCAGAAAGCCACGGCTAACTACGTGCCAGCAGCCGCGGTAATACGTAGGTGGCAAGCGT TGTCCGGATTTATTGGGCGTAAAGCGAGCGCAGGCGGTTTTTTAAGTCTGATGTGAAAGCCTTCGGCTCAACCGAAGAAGTGCATCGGAAACTGGGAAACTTGAGTGCAGAAGAGGAC AGTGGAACTCCATGTGTAGCGGTGAAATGCGTAGATATATGGAAGAACACCAGTGGCGAAGGCGGCTGTCTGGTCTGTAACTGACGCTGAGGCTCGAAAGTATGGGTAGCAAACAGGA TTAGATACCCTGGTAGTCCATACCGTAAACGATGAATGCTAAGTGTTGGAGGGTTTCCGCC CTTCAGTGCTGCAGCTAACGCATTAAGCATTCCGCCTGGGGAGTACGGCCGCAAGGCTGAAACTCAAAGGAATTGACGGGGGCCCGCACAAGCGGTGGAGCATGTGGTTTAATTCGAAGCTACGCGAAGAACCTTACCAGGTCTTGACATACTATGCAAATCTAAGAGATTAGACGTTCCCTTCGGGGACATGGATACAGGTGGTGCATGGTTGTCGTCAGCTCGTGTCGTGAGATGTT GGGTTAAGTCCCGCAACGAGCGCAACCCTTATTATCAGTTGCCAGCATTAAGTTGGGCAC TCTGGTGAGACTGCCGGTGACAAACCGGAGGAAGGTGGGGATGACGTCAAATCATCATGCCCCTTATGACCTGGGCTACACACGTGCTACAATGGATGGTACAACGAGTTGCGAACTCG CGAGAGTAAGCTAATCTCTTAAAGCCATTCTCAGTTCGGATTGTAGGCTGCAACTCGCCTACATGAAGTCGGAATCGCTAGTAATCGCGGATCAGCATGCCGCGGTGAATACGTTCCCGGG CCTTGTACACACCGCCCGTCACACCATGAGAGTTTGTAACACCCAAAGTCGGTGGGGTAACCTTTTAGGAACCAGCCGCCTAAGGTGACAGATGGG.

[0041] The successfully sequenced sequences were compared and analyzed using the BLAST (Basic Local Alignment Search Tool) program in NCBI, and it was confirmed that strain KSFY01 was Lactobacillus plantarum.

[0042] 1.1.5 Deposit of strain KSFY01

[0043] The strain KSFY01 was classified and named Lactobacillus plantarum and was deposited in the General Microbiology Center of China Culture Collection Administration (CGMCC, address: No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, China) on April 28, 2018, with the deposit number: CGMCC No.15654.

[0044] 1.1.6 Preparation of Lactobacillus plantarum KSFY01 bacterial suspension

[0045] The bacteria frozen at -80℃ were inoculated into sterile MRS medium for resuscitation. The resuscitation conditions were: 37℃, culture for 18-24h, and two generations were activated in total. The second generation bacterial suspension was taken and centrifuged at 5000r / min for 10min. The upper layer of culture medium was discarded and the same volume of 0.9% saline was added to re-prepare the bacterial suspension.

[0046] 1.2 Experimental Animal Grouping and Dosing

[0047] The present invention utilizes D-galactose to establish a mouse aging model, and selects 50 male Kunming mice, 6 weeks old, purchased from the Animal Experiment Center of Chongqing Medical University. Before the formal experiment, mice were placed in a 12-hour light / dark cycle for adaptive feeding for one week, with free diet and drinking water. After the end of the one-week adaptation period, mice were evenly divided into 5 groups (10 per group), divided into a normal group, a model group, a vitamin C group (VitC), a KSFY01 high-dose group (KSFY01-H) and a KSFY01 low-dose group (KSFY01-L). The experimental period was 10 weeks, and after the experiment started, the rest of the mice in the groups except the normal group were intraperitoneally injected with D-galactose solution (120 mg / kg) daily for 6 weeks, and the normal group mice were intraperitoneally injected with an equal amount of normal saline. From the 7th week, mice in the normal group and the model group were gavaged with distilled water (0.02 mL / kg bw) daily; mice in the VitC group were gavaged with 150 mg / kg bw vitamin C daily; mice in the KSFY01-H group were gavaged with L. plantarum KSFY01 suspension daily, with a dose of 1.0×10 10 CFU / kg; mice in the KSFY01-L group were gavaged daily with L. plantarum KSFY01 suspension at a dose of 1.0×10 9 CFU / kg, and continued intragastric administration for 4 weeks. After 10 weeks, the mice were subjected to a running exhaustion test, and the exhaustion time of each group of mice was recorded. Then, the mice were immediately killed by dislocating the neck after blood was drawn from their eyeballs, and their liver and kidney tissues were quickly taken for subsequent experiments. Figure 2 It is a schematic diagram of the experimental design process of the present invention.

[0048] 1.3 Mouse running experiment

[0049] After 10 weeks, the mice were subjected to a running exhaustion experiment. The running wheel was set to 20 rpm / min, and the mice were forced to run on the wheel. When the mice stopped running, they were given electric shocks for 5 consecutive times until exhaustion. The running time of this process was recorded.

[0050] 1.4 Determination of biochemical and energy metabolism indicators in mouse serum

[0051] Take the eyeball blood of mice in a 1.5mL centrifuge tube, place it in a 4℃ refrigerator for 30min and then centrifuge it. Centrifugation conditions: 3000rpm, 4℃, 10min; take an appropriate amount of serum, and use a biochemical kit to determine the levels of blood urea nitrogen (BUN), free fatty acids (NEFA), lactate (LD), lactate dehydrogenase (LDH), catalase (CAT), glutathione (GSH), malondialdehyde (MDA) in mouse serum and muscle glycogen in muscle. At the same time, enzyme-linked immunosorbent assay was also used to determine the activities of aspartate aminotransferase (AST), alanine aminotransferase (ALT), and creatine kinase (CK) in mouse serum.

[0052] 1.5 Pathological section observation of mouse liver and kidney

[0053] After the mouse was dissected, part of the mouse liver and kidney tissues were immediately taken and fixed in 10% neutral formalin solution. The fixed tissues were then dehydrated at 4°C for 48 hours, and then the tissue samples were embedded in paraffin. The embedded tissues were cut into 5-10 μm slices and stained with hematoxylin-eosin (H&E) dye. Finally, the pathological changes of the tissues were observed under an optical microscope.

[0054] 1.6 Real-time fluorescence quantitative PCR

[0055] Real-time quantitative PCR (RT-qPCR) was used to measure the mRNA expressions of SOD1, SOD2, CAT, interleukin 1β (IL-1β), tumor necrosis factor α (TNF-α), interleukin 10 (IL-10), heme oxygenase 1 (HO-1), nuclear factor-erythroid 2-related factor 2 (Nrf2), γ-glutamylcysteine ​​synthetase (γ-GCS), and NAD(P)H dehydrogenase [quinone] 1 (NQO-1) in the liver and muscle tissues of mice.

[0056] The first step is to extract RNA from the liver and muscle tissue. Take out the mouse liver tissue and muscle tissue from the -80℃ refrigerator, weigh 100 mg into a homogenize tube, add 1mL TRIzol reagent and homogenize beads for extraction. The second step is to use a nucleic acid analyzer to determine the concentration of the extracted RNA. Subsequent experiments can only be performed when the purity value is between 1.8-2.0. The third step is to use the Thermo Fisher kit to reverse transcribe the RNA into cDNA according to the steps, divide the cDNA into portions, and store it in a -80℃ refrigerator for later use. The fourth step is to use the reverse transcribed cDNA as a template, add a fluorescent dye, and place it in a fluorescent quantitative PCR instrument for reaction. The RT-PCR reaction system is 20μL, and the reaction conditions are: preheating at 95℃ for 60s, 95℃ for 15s, 55℃ for 30s, 72℃ for 35s, 40 cycles, and finally test at 95℃ for 30s and 55℃ for 35s. Each reaction is performed 4 times. The β-actin gene was used as the internal reference gene in the experiment, and 2 -ΔΔCt The relative expression level of target mRNA was determined by relative quantification method. The primer sequences of reference genes and target genes used in this study are shown in Table 1.

[0057] Table 1 Primer sequences used for real-time quantitative PCR

[0058]

[0059]

[0060] 1.7 Data Analysis

[0061] All data were expressed as mean ± standard deviation (mean ± SD) and plotted using Graph Pad Prism (version 7.00) software. SPSS software (SPSS 22.0, SPSS Inc.) was used for statistical analysis of the data, and ANOVA analysis and Duncan's test were used to evaluate the significance of differences in various parameters of the samples (p < 0.05).

[0062] 2 Results

[0063] 2.1 Effect of Lactobacillus plantarum KSFY01 on exercise endurance in aging mice

[0064] Depend on Figure 3 It can be seen that the running time of mice in the normal group was the longest among all groups, while the running time of the aging model group was the shortest. Compared with the aging model group, L. plantarum KSFY01 and vitamin C could significantly (p<0.05) prolong the running time of aging mice, and the high-dose group of L. plantarum KSFY01 had the best prolongation effect, which was significantly better than the low-dose group of L. plantarum KSFY01 and the Vit C group.

[0065] 2.2 Energy metabolism indicators of mice

[0066] As shown in Table 2, the levels of BUN, NEFA and LD in the serum of the normal group of mice were significantly (P<0.05) lower than those in the other groups, while the levels of MG and LDH were significantly (P<0.05) higher than those in the other groups. The above indicators in the serum of the mice in the aging model group showed an opposite trend to that of the normal group. Compared with the aging model group, L. plantarum KSFY01 and vitamin C can reduce the levels of BUN, NEFA and LD in the serum of aging mice, while increasing the levels of LDH and MG. The experimental results show that L. plantarum KSFY01 can reduce the BUN produced by mice after exercise, increase the activity of LDH, reduce the content of LD, and relieve the fatigue of mice.

[0067] Table 2 Levels of BUN, NEFA, LD, LDH in serum and MG in muscle tissue of mice

[0068]

[0069] Note: Data are expressed as mean ± standard deviation. ae Values ​​with different superscripts in the same column are significantly different (P<0.05). Vit C: mice treated with vitamin C (200 mg / kg); KSFY01-H: mice treated with Lactobacillus plantarum KSFY01 (1×10 10 CFU / kg); KSFY01-L: mice treated with Lactobacillus plantarum KSFY01 (1×10 9 CFU / kg).

[0070] 2.3 Motor injury indicators in mice

[0071] As shown in Table 3, the ALT, AST, and CK contents of the vitamin C, L. plantarum KSFY01 high- and low-dose groups were between the model group and the normal group. Both L. plantarum KSFY01 bacterial suspension and vitamin C had a good effect in alleviating the increase in ALT, AST, and CK contents caused by D-galactose. The high-dose L. plantarum KSFY01 group and the vitamin C group had better effects than the low-dose L. plantarum KSFY01 group.

[0072] Table 3 ALT, AST and CK levels in mouse serum

[0073]

[0074] Note: Data are expressed as mean ± standard deviation. Values ​​in the same column with different letters indicate significant differences (P<0.05).

[0075] 2.4 Antioxidant indicators of mice

[0076] As shown in Table 4, this study detected the levels of catalase, glutathione and peroxide MDA in serum. Compared with the normal group, the CAT enzyme activity in the model group decreased significantly (p<0.05), and the GSH content also decreased significantly. After intervention with vitamin C and L. plantarum KSFY01, the CAT enzyme activity in serum was improved, and the effect of high-dose L. plantarum KSFY01 was better than that of vitamin C and low-dose L. plantarum KSFY01. Compared with the model group, vitamin C and L. plantarum KSFY01 significantly reduced the MDA content (p<0.05), and the high-dose L. plantarum KSFY01 had the best effect.

[0077] Table 4 CAT, GSH and MDA levels in mouse serum

[0078]

[0079] 2.5 Analysis of mouse liver and kidney tissue sections

[0080] Mouse liver tissue morphology under microscope Figure 4 The liver lobule structure of mice in the normal group was clear and intact, and there was no obvious change in liver cells, and no granular degeneration, vacuolar degeneration, hepatocyte enlargement, necrosis, etc. The liver lobule structure of mice in the D-galactose-induced aging model group was destroyed, the arrangement of hepatocytes was chaotic, and many vacuoles of varying sizes appeared in the cytoplasm. Inflammatory infiltration accompanied by cell necrosis was also observed under the microscope. Vitamin C and L. plantarum KSFY01 can both reduce the damage of liver cells in aging mice. After the action of KSFY01-H, the liver lobule structure was basically intact, the hepatocyte degeneration was significantly improved, the cell boundaries were relatively clear, and the morphology was relatively complete. In addition, many vacuoles of varying sizes appeared in the cytoplasm of liver tissues of mice in the KSFY01-L group and the Vc group.

[0081] The morphology of mouse kidney tissue under a microscope Figure 5 In the normal group, the glomerular vascular loops were thin and clear. The number of endothelial cells and mesangial cells was normal. The surrounding renal tubules were also normal. The glomeruli in the kidney tissue of the mice in the aging model group were irregular in shape, some glomeruli were ruptured, the glomeruli were swollen, and there was inflammatory cell infiltration between the tissues. Vitamin C and L. plantarum KSFY01 can both reduce kidney tissue damage caused by aging, and the infiltration of inflammatory cells decreased to varying degrees.

[0082] 2.6 mRNA expression in liver tissue

[0083] like Figure 6 and Figure 7 The expression intensity of IL-1β and TNF-α mRNA in the liver tissue of mice in the normal group was the weakest ( Figure 6 EF), IL-10, Cu / Zn-SOD (SOD1), Mn-SOD (SOD2), CAT, HO-1, Nrf2, γ-GCS and NQO1 were expressed most strongly ( Figure 6 AD and Figure 7 In the aging model group, the expression of IL-1β and TNF-α was the strongest, and the expression of IL-10, Cu / Zn-SOD, Mn-SOD, CAT, HO-1, Nrf2, γ-GCS and NQO1 was the weakest. Vitamin C and L. plantarum KSFY01 can down-regulate the expression of IL-1β and TNF-α and up-regulate the expression of IL-10, Cu / Zn-SOD, Mn-SOD, CAT, HO-1, Nrf2, γ-GCS and NQO1 in the liver tissue of aging mice, and the high-dose group of L. plantarum KSFY01 has the strongest regulatory ability on these expressions, making these expressions close to those of normal mice.

[0084] 2.7 mRNA expression in muscle tissue

[0085] We also analyzed the genes related to the Nrf2 pathway in mouse muscle tissue. IL-10, IL-1β, TNF-α, SOD1, SOD2, CAT, HO-1, Nrf2, γ-GCS, and NQO1 are oxidative genes in this pathway. When Nrf2 expression changes, these genes will be abnormally expressed. Figure 8 Medium AF and Fig. 9 As shown in Figures AD, compared with the normal group, the expression levels of IL-10, Cu / Zn-SOD, Mn-SOD, CAT, HO-1, Nrf2, γ-GCS and NQO1 mRNA in the muscle tissue of the model group were significantly decreased (p < 0.05), and the expression intensity of IL-1β and TNF-α mRNA was significantly increased (p < 0.05). Compared with the model group, vitamin C and L. plantarum KSFY01 intervention greatly improved the expression of these genes (p < 0.05), making them closer to the normal group. In addition, the regulatory effect of L. plantarum KSFY01 was enhanced in a dose-dependent manner. The regulatory effect of high-dose L. plantarum KSFY01 was better than that of low-dose L. plantarum KSFY01. The results showed that L. plantarum KSFY01 had a positive effect on muscle damage in mice caused by aging.

[0086] 3 Results Analysis

[0087] In this study, an aging mouse model was established by intraperitoneal injection of D-galactose to observe the effect of L. plantarum KSFY01 on endurance running of mice, so as to verify the intervention effect of L. plantarum KSFY01 on exercise capacity in the aging state. The experimental results confirmed that L. plantarum KSFY01 can prolong the endurance running time of mice, enhance exercise capacity, and relieve fatigue.

[0088] Long-term continuous exercise is an important cause of fatigue in the body. This study designed a high-intensity exercise treadmill experiment to cause mice to experience exercise fatigue. Serum LA, LDH and BUN levels can indicate the speed and degree of fatigue development. In addition, the physical exhaustion of mice during long-term high-intensity exercise is related to changes in MG content. After a period of exercise, the glycogen in the body will break down into lactic acid and release energy to supply muscle movement. The more MG reserves, the better the body's endurance and the longer the exercise time. In this study, compared with the model group, vitamin C and L. plantarum KSFY01 interventions significantly reduced the accumulation of these metabolites and regulated blood sugar levels. Among them, L. plantarum KSFY01 also reduced muscle damage by regulating LDH levels. This shows that L. plantarum KSFY01 can relieve fatigue by effectively reducing the accumulation of metabolic byproducts, improving muscle damage and increasing energy storage.

[0089] There is increasing evidence that high-intensity exercise or acute training may damage liver cells by reducing blood flow to the liver and portal vein, often causing hepatocyte hypoxia and ultimately leading to liver necrosis. This damage is usually accompanied by elevated levels of CK, AST, and ALT. This study also found that exercise fatigue caused a significant increase in serum CK, ALT, and AST levels of liver function indicators, causing liver dysfunction, which could be reversed by the intervention of vitamin C and L. plantarum KSFY01.

[0090] During exercise, many free radicals are generated, such as hydroxyl radicals and superoxide anion radicals, called reactive oxygen species (ROS). This phenomenon is particularly evident in the aging state. CAT, GSH, etc. are important antioxidants and free radical scavengers that the human body possesses. Their presence can maintain the normal oxidative stress level of the body and remove excess free radicals. In addition, excessive accumulation of ROS will cause oxidative stress and attack biological macromolecules, such as lipids, proteins, nucleic acids, etc., to form lipid peroxidation products MDA. MDA further destroys the structure of the cell membrane, causing cell swelling and then necrosis. Therefore, the level of MDA in the body can also indirectly reflect the changes in the body's free radical metabolism and the degree of tissue peroxidation damage. After intervention with vitamin C and L. plantarum KSFY01, the content of MDA in the blood of mice was reduced, and the content of CAT and GSH was increased. Therefore, the results of this study show that L. plantarum KSFY01 has effective antioxidant activity, inhibits aging, and plays an effect of enhancing exercise endurance and ability.

[0091] In terms of oxidative stress, in order to clarify the molecular mechanism by which L. plantarum KSFY01 affects fatigue and fatigue-related organ dysfunction in the aging state, we evaluated the expression of oxidative stress-related signaling genes in liver and muscle tissues. At present, many studies have shown that the Nrf2 signaling pathway is an extremely important endogenous defense system of the body. Among them, nuclear factor--E2-relatedfactor2 (Nrf2) is the most critical factor in resisting cellular oxidative stress response. Nrf2 mainly interacts with antioxidant response elements (ARE) to induce the expression of encoded antioxidant proteins and phase II detoxification enzymes, thereby resisting harmful stimuli in cells and playing an important protective role in cells. The downstream antioxidant enzymes encoded by the Nrf2 signaling pathway mainly include: γ-GCS, SOD, CAT, etc. The downstream phase II detoxification enzymes regulated are mainly: HO-1, NQO1, GCL, etc. In addition, oxidative stress reaction generates a large amount of ROS, causing peroxidation damage, and the increase of ROS in mitochondria can lead to advanced lipid oxidation, generate more lipid peroxides, and induce the production of tumor necrosis factor TNF-α. TNF-α not only damages the function of mitochondrial respiratory chain and affects the electron transfer on the respiratory chain, but also opens the permeability transition channel of mitochondria, depletes cytochrome C in mitochondria, and then triggers liver cell apoptosis and necrosis. In this study, RT-PCR was used to analyze whether vitamin C and L. plantarum KSFY01 can affect the expression of these genes. The results showed that high-intensity exercise caused a decrease in the expression levels of Nrf2, NQO1, γ-GCS, HO-1, SOD1, SOD2, CAT and IL-10 mRNA in liver and muscle tissues, while vitamin C and L. plantarum KSFY01 significantly increased their expression, and the intervention and regulation of L. plantarum KSFY01 was more significant. The intervention effect of L. plantarum KSFY01 was dose-dependent, and the intervention effect of high-dose L. plantarum KSFY01 was better than that of low-dose L. plantarum KSFY01. These findings suggest that the Nrf2 pathway is the potential molecular mechanism for L. plantarum KSFY01 to exert its antioxidant and anti-fatigue effects.

[0092] 4 Conclusion

[0093] This study established a mouse aging model to explore the antioxidant effect of L. plantarum KSFY01 and its effect on improving the motor function of mice. The experimental results showed that L. plantarum KSFY01 can improve the fatigue resistance and motor ability of aging mice by improving metabolite accumulation, glycogen storage, muscle and liver damage, and oxidative stress. This provides a reference for the future development of food-borne antioxidants for anti-fatigue and improving motor function in the elderly, which is of great significance to the development and utilization of probiotic resources.

[0094] The embodiments described above are only descriptions of the preferred modes of the present invention, and are not intended to limit the scope of the present invention. Without departing from the design spirit of the present invention, various modifications and improvements made to the technical solutions of the present invention by ordinary technicians in this field should all fall within the protection scope determined by the claims of the present invention.

Claims

1. An application of Lactobacillus plantarum KSFY01 in preparing a product for improving body athletic ability, anti-oxidation and anti-fatigue ability, characterized in that: The Lactobacillus plantarum KSFY01 has been deposited in the General Microbiological Center of China Microbiological Culture Collection Committee with a deposit number of CGMCC NO.15654, a deposit address of No. 3, Yard No. 1, Beichen West Road, Chaoyang District, Beijing, China, and a deposit date of April 28, 2018; The Lactobacillus plantarum KSFY01 is isolated from yogurt.

2. The use according to claim 1, characterized in that: By improving the body's exercise endurance, improving metabolite accumulation and alleviating body damage, the effect of relieving fatigue and improving the body's exercise ability can be achieved.

3. The use according to claim 2, characterized in that: The improvement of metabolite accumulation specifically refers to reducing the levels of CK, ALT and AST in the body's serum.

4. The use according to claim 2, characterized in that: The alleviating body damage includes alleviating liver, kidney and muscle damage; and the body includes an aging body.

5. The use according to claim 1, characterized in that: The Lactobacillus plantarum KSFY01 improves the body's antioxidant capacity by regulating the molecular expression of the body's Nrf2 signaling pathway.

6. A product for improving the body's athletic ability, anti-fatigue ability and slowing down the body's aging, characterized in that: The product comprises an effective dose of the Lactobacillus plantarum KSFY01 described in claim 1.

7. The product according to claim 6, characterized in that The plant lactobacillus KSFY01 comprises a plant lactobacillus KSFY01 bacterial suspension, and the effective dose of the bacterial suspension in the body is 1.0×10 9 -1.0×10 10 CFU / kg.

Citation Information

Patent Citations

  • Lactobacillus plantarum and application thereof

    CN105567601A

  • Application of lactobacillus plantarum CQPC02 in preparation of food or medicine capable of preventing oxidative injury of livers

    CN109619184A

  • Application of lactobacillus plantarum Y44 in preparation of antioxidant probiotic product

    CN111903983A

  • Lactobacillus plantarum Y44 and application thereof in preparation of medicines or health care products for relieving obesity or resisting hyperlipidemia

    CN111909869A

  • Application of lactobacillus plantarum in promoting liver regeneration

    CN112656819A

Cited By

  • A kind of plant lactobacillus J0334 and culture medium thereof

    CN119020224B